Next Generation Molecular Assay Market Segmentation:
Technique Segment Analysis
By the end of 2035, polymerase chain reaction segment is expected to dominate around ~41% next generation molecular assay market share. PCR assay plays a fundamental role in sequencing as the methods for sequence-ready NGS libraries involve PCR steps, making it a useful and effective technique for next generation molecular assay. When a PCR test was performed on brucellosis (a zoonotic disease) for rapid diagnosis, the results obtained showed that 7% of cases had positive PCR. Moreover, PCR assays are considered to be more accurate than serological tests and blood culture techniques.
Application Segment Analysis
Pharmaceutical segment in the next generation molecular assay market is set to exhibit CAGR of around 6% from 2026 to 2035. PCR and ELISA when combined help in the identification of challenging disease agents where clinical signs are not visible and are also used in the R&D of new vaccines and drugs by pharmaceutical companies.ELISA test is performed to detect blood-borne diseases such as HIV.
Our in-depth analysis of the market includes the following segments:
|
Technique |
|
|
Application |
|
|
Type |
|
